Medtech Infrastructure Investments to Fuel $87 Billion Growth by 2035

The medtech sector is entering a new growth phase centered on foundational infrastructure, with global value projected to rise from $420 billion in 2024 to $507 billion by 2035—a compound annual growth rate of 1.9%. This expansion is not driven by device innovation alone, but by investments in scalable digital health infrastructure, interoperable data systems, and advanced manufacturing networks. A critical component of this shift is the modernization of healthcare IT ecosystems, with global spending on medical infrastructure expected to reach $87 billion between 2025 and 2035. Companies such as LAMR (Lumenis Ltd.) are expanding their platforms for minimally invasive surgical systems, while ISRG (Intuitive Surgical) continues to deepen integration of AI across robotic-assisted procedures. Meanwhile, MDT (Medtronic plc) is advancing its connected device ecosystem, enhancing remote monitoring and predictive maintenance capabilities. These developments are supported by public and private capital flows—projected to exceed $23 billion in dedicated medtech infrastructure funding through 2030. The emphasis on resilient supply chains, particularly for implantable devices and critical diagnostic tools, is accelerating investments in regional manufacturing hubs and blockchain-enabled traceability systems. The impact is already visible in stock performance: LAMR has seen a 14% year-to-date gain, ISRG a 9% increase, and MDT a 7% rise, reflecting investor confidence in infrastructure-led growth. Hospitals, health systems, and medical device manufacturers are all adapting to the new paradigm, where system integration and data reliability are as vital as clinical efficacy.